Core Insights - Hong Kong Stock Exchange data indicates that on October 9, Huakang Biomedical (08622) shareholders transferred stocks from Qingtian Securities to Jinlifeng Securities, with a transfer market value of HKD 54.8386 million, accounting for 27.74% of the total [1] Group 1 - On October 9, Huakang Biomedical and the offeror Anselme Limited jointly announced a sale and purchase agreement, where the seller Li Jingyang conditionally agreed to sell and the offeror conditionally agreed to acquire all legal and beneficial ownership and rights of the shares (1.387 billion shares), representing approximately 27.71% of the total issued share capital as of the announcement date, for a total consideration of HKD 17.4727 million, equivalent to HKD 0.126 per share [1]
华康生物医学股东将股票由擎天证券转入金利丰证券 转仓市值5483.86万港元